1. Home
  2. TKR vs TGTX Comparison

TKR vs TGTX Comparison

Compare TKR & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Timken Company (The)

TKR

Timken Company (The)

HOLD

Current Price

$131.89

Market Cap

9.2B

Sector

Industrials

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$49.65

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKR
TGTX
Founded
1899
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
8.5B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
TKR
TGTX
Price
$131.89
$49.65
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$118.29
$49.80
AVG Volume (30 Days)
833.4K
2.2M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
1746.67
EPS
1.81
0.12
Revenue
$80,100,000.00
$2,785,000.00
Revenue This Year
$4.57
$49.08
Revenue Next Year
$3.97
$26.69
P/E Ratio
$94.31
$406.13
Revenue Growth
N/A
N/A
52 Week Low
$70.79
$25.37
52 Week High
$146.37
$59.30

Technical Indicators

Market Signals
Indicator
TKR
TGTX
Relative Strength Index (RSI) 42.63 41.49
Support Level $105.06 $28.57
Resistance Level $144.78 $58.08
Average True Range (ATR) 4.96 2.56
MACD -0.97 -1.12
Stochastic Oscillator 32.97 31.61

Price Performance

Historical Comparison
TKR
TGTX

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The various products offered by the company include ball bearings, plain bearings, tapered roller bearings, housed bearings, linear guides, telescopic rails, lubrication systems, agricultural conveyor chains, couplings, brakes, seals, etc. These products are offered through brands like Timken, GGB, Philadelphia Gear, Cone Drive, CGI, and Rollon, among others. The company has two reportable segments: Engineered Bearings, which generates the maximum revenue, and Industrial Motion. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Africa (EMEA), Asia-Pacific, and the other regions of the Americas.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

Share on Social Networks: